US 7196184
Double-stranded RNA (DSRNA) and method of use for inhibiting expression of the AML-1/MTG8 fusion gene
granted A61KA61K38/00A61P
Quick answer
US patent 7196184 (Double-stranded RNA (DSRNA) and method of use for inhibiting expression of the AML-1/MTG8 fusion gene) held by Alnylam Europe AG expires Mon Mar 22 2027 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Alnylam Europe AG
- Grant date
- Tue Mar 27 2007 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 22 2027 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 2
- CPC classes
- A61K, A61K38/00, A61P, A61P35/00